Second round of inflation-related rebates hits 43 drugs from Amgen, Seagen, AbbVie and others
The Department of Health and Human Services on Friday revealed its latest round of coinsurance savings for seniors on drugs with prices rising faster than the rate of inflation.
For the upcoming period of July 1 to Sept. 30, the Centers for Medicare & Medicaid Services said 43 Part B drugs will have an adjusted coinsurance rate based on the inflation-adjusted payment amount. That translates into lower rates for seniors, with savings anywhere from $1 to $449 per dose — up from $372 per dose in the first list from April, CMS said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.